Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 10 hours agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Virax Biolabs Group Limited (NASDAQ:VRAX) Sees Significant Increase in Short Interest
ETF DAILY NEWS· 1 day agoVirax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 47,000 ...
Bird flu tests are hard to get: Researchers warn US could be caught off guard by a pandemic
Medical Xpress· 24 hours agoStanford University infectious disease doctor Abraar Karan has seen a lot of patients with runny...
Scientists use gene technology to develop possible antidote to black widow spider bite
United Press International via Yahoo News· 3 days agoIn severe cases, people might need hospitalization to treat high blood pressure, heart problems or...
New antivenom invented for black widow spider bites
Live Science via Yahoo News· 3 days agoIn all, the team identified 45 human antibodies that could do this, including one in particular, called MRU44-4-A1, which showed "outstandingly" high...
Unpicking the complexity of systemic sclerosis
Medical Xpress· 17 hours agoSSc is a connective tissue disease with variable clinical presentation. It may affect the skin, blood vessels, heart, lungs, kidneys, gastrointestinal tract, and musculoskeletal system—and this ...
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Zacks via Yahoo Finance· 21 hours agoAbcam's track record of innovation, outstanding product quality and breadth of antibody portfolio...
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 49.0% in May
ETF DAILY NEWS· 2 days agoBiomerica, Inc. (NASDAQ:BMRA – Get Free Report) saw a large decrease in short interest during the month of May. As of May 31st, there was short interest totalling 175,200 shares, a decrease ...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 5 days agoIn Moderna’s study, mRNA-1083 was tested in two groups of 4,000 adults. In one, adults aged 65 years...
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 5 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...